Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Ranbaxy Laboratories: Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG
News Announcement

Ranbaxy Laboratories: Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG

05-Nov-2014 Follow Value Research Online on Google Ranbaxy Lab

Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated November 05, 2014 titled 'Ranbaxy receives approval from US FDA to market Fenofibrate Capsules USP, 43 MG and 130 MG'.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds